title: Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia.
abstract: OBJECTIVE
  To evaluate the extent to which parents are satisfied with and understand the information they are given when their consent is sought for their child to participate in a phase III randomised clinical trial and the reasons for their decision.
  
  
  METHODS
  The authors carried out a prospective study. The authors included all parents whose consent was sought for their child to participate in the FRALLE 2000A protocol (acute lymphoblastic leukaemia) at two centres. The parents were questioned twice by a qualified psychologist using a semidirected interview, 1 and 6 months after consent was sought.
  
  
  RESULTS
  43 first interviews were carried out. All the parents declared they were satisfied with the explanations provided by the physician. 35 (81%) parents felt that the information provided with the request for consent was appropriate. Eight (19%) parents did not realise that their child had been included in a research protocol. 16 (39%) parents did not understand the concept of randomisation. Half the parents could explain neither the aim of the clinical trial nor the potential benefit of inclusion to their child. Only one third of the parents were aware that they had an alternative. The principal factor underlying their decision, as stated by 29 parents (67%), was confidence in the medical team.
  
  
  CONCLUSIONS
  The parents signed consent forms without having fully understood all the elements specific to the experimental protocol. Rather, the parents based their decision on their confidence in the medical team, even when their child's life was at risk.
authors.affiliation: Service d'Urgences Pédiatriques, Hôpital Necker Enfants Malades, 149 rue de Sèvres, 75743 Paris Cedex 15, France. helene.chappuy@nck.aphp.fr
authors.forename: H
authors.initials: H
authors.lastname: Chappuy
authors.forename: A
authors.initials: A
authors.lastname: Baruchel
authors.forename: G
authors.initials: G
authors.lastname: Leverger
authors.forename: C
authors.initials: C
authors.lastname: Oudot
authors.forename: B
authors.initials: B
authors.lastname: Brethon
authors.forename: S
authors.initials: S
authors.lastname: Haouy
authors.forename: A
authors.initials: A
authors.lastname: Auvrignon
authors.forename: D
authors.initials: D
authors.lastname: Davous
authors.forename: F
authors.initials: F
authors.lastname: Doz
authors.forename: J M
authors.initials: JM
authors.lastname: Tréluyer
mesh_terms: D002648:Child; D002675:Child, Preschool; D017326:Clinical Trials, Phase III as Topic; D032882:Comprehension; D003258:Consumer Behavior / Q000706:statistics & numerical data; D003657:Decision Making; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007223:Infant; D007258:Informed Consent / Q000523:psychology*; D008297:Male; D010290:Parents / Q000523:psychology*; D018579:Patient Selection; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic